Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Submitted by
admin
on April 24, 2017 - 10:07am
Source:
Marketwatch
News Tags:
Eli Lilly
advanced breast cancer
clinical trials
abemaciclib
Headline:
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Do Not Allow Advertisers to Use My Personal information
